June 12th 2025
Phase 3 results show immune response and tolerability in adults 65 and older, following phase 2 findings.
What Do Stakeholders Think About the GAP for Influenza Vaccines' First 10 Years?
December 5th 2016Ten years ago in Geneva, the World Health Organization (WHO) unveiled what is now called the Global Action Plan for Influenza Vaccines (GAP), a comprehensive approach to meeting the demand for vaccines should there be a pandemic anywhere in the world. How is it doing?
Read More
Pandemic Influenza Top of Mind for CDC Director
November 30th 2016Thomas Frieden, MD, MPH, director of the CDC, and Susan Desmond-Hellmann, MD, chief executive of the Bill and Melinda Gates Foundation discuss how governments and business organizations should prepare for pandemics, especially a potential influenza pandemic.
Read More
Poultry Culled and Quarantines Up as Bird Flu Outbreak Hits South Korea
November 28th 2016A recent outbreak of highly pathogenic avian influenza in commercial chickens and ducks in South Korea has health officials in the country on high alert and some poultry farmers taking quarantine measures.
Read More
Influenza Antiviral Treatments: Prescribing Practices Across the US
November 8th 2016Rebekah Stewart Schicker, MSN, MPH, APRN, Epidemic Intelligence Service (EIS) Officer at the Centers for Disease Control and Prevention, explains her recent research on influenza antiviral treatment prescribing practices in 60 outpatient settings across the United States.
Watch
Effectiveness of Influenza Antiviral Treatment in Outpatient Settings
November 2nd 2016Rebekah Stewart Schicker, MSN, MPH, APRN, Epidemic Intelligence Service (EIS) Officer at the Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Influenza Division, explains how antiviral flu treatments may be affecting patients in the outpatient setting.
Watch
Populations at Risk for Flu-associated Complications and Recommended Treatments
October 29th 2016Rebekah Stewart Schicker, MSN, MPH, APRN, Epidemic Intelligence Service (EIS) Officer at the Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Influenza Division, discusses which outpatient populations are at highest risk of influenza-associated complications and the recommended treatments for these individuals.
Watch
Healthcare Provider Attitudes Toward Seasonal Influenza Vaccine Policies
October 8th 2016To assess factors associated with the likelihood that healthcare providers will accept seasonal influenza vaccine policy changes, Nova Scotia researchers examined the roles that their knowledge and attitude play in the matter.
Read More